# A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor

> **NCT01760343** · PHASE1 · COMPLETED · sponsor: **CSL Behring** · enrollment: 16 (actual)

## Conditions studied

- Hereditary Angioedema Types I and II

## Interventions

- **BIOLOGICAL:** Berinert
- **BIOLOGICAL:** CSL830

## Key facts

- **NCT ID:** NCT01760343
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2013-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01760343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01760343, "A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01760343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*